Features of ESG transformation of pharmaceutical companies in Russia

In this article the activities of transnational pharmaceutical companies in the field of ESG are examined, also trends in the Russian pharmaceutical market is shown, and the Top 10 Russian companies for the presence of ESG activities are analyzed. Since there is no single approach to identifying criteria for assessing the effectiveness of activities in the ESG field, and they depend on the specifics of the industry, the author proposes such criteria for pharmaceutical companies in Russia.